Micropep Raises $29M in Series B Funding and Unveils Krisalix, its Proprietary Discovery Platform
25 Julio 2024 - 5:00AM
Business Wire
New Investment Round to Fuel Micropep's Mission
of Tackling Global Food Production Challenges with Innovative,
Sustainable Micropeptide Solutions
Micropep Technologies (Micropep), the global leader in
micropeptide technology, today announced a $29 million Series B
funding round along with its proprietary discovery platform,
Krisalix. The round was led by Zebra Impact Ventures, and BPI Green
Tech Investment. All existing investors, Fall Line Capital, FMC
Ventures, Sofinnova Partners, Supernova Invest, and IRDI Capital
Investissement also participated, bringing the company’s total
funding to more than $51.8 million.
Micropep plans to use the Series B funding to accelerate
go-to-market strategy through partnerships, complete the regulatory
studies of the first biofungicide molecule, and expand its pipeline
of micropeptide active ingredients on the Krisalix™ platform.
Investor Support
"Micropep's pioneering micropeptide technology holds immense
promise for revolutionizing agriculture sustainably,” said Lionel
Artusio, General Partner, Zebra Impact Ventures. “By backing the
Micropep team, we're excited to contribute to the growth of
Micropep as a leader in nature-inspired agricultural innovation,
fostering a healthier planet for future generations.”
“At Fall Line, we are thrilled to reinvest in Micropep at this
pivotal stage,” said Baptiste Tellier, Managing Director of Fall
Line Capital. “Micropep is strategically positioned to pioneer new,
environmentally safe crop protection products. Our renewed
investment is driven by the impressive strides the company has made
over the past few years. Notably, Micropep has maintained the field
efficacy of its micropeptides while reducing doses in field trials
and lowering biomanufacturing costs. The integration of advanced
generative artificial intelligence tools into its discovery
platform has also significantly shortened design turnaround time.
These remarkable achievements underscore the tremendous potential
of Micropep.”
Micropep's Proprietary Discovery Platform
Micropep unveils its proprietary discovery platform, Krisalix,
along with this round of funding. Krisalix enables the company to
discover new micropeptide-based active ingredients much faster and
more efficiently than traditional methods. Finding the correct
micropeptide sequence for a given function is not easy. Turning it
into an efficient and affordable product that farmers can use is
even more complicated. Krisalix combines proprietary micropeptide
design algorithms with a unique suite of bioassays to measure
efficacy, stability, and production feasibility. Together, these
capabilities enable Micropep to rapidly discover the most promising
micropeptide molecules for crop protection.
"This new round of funding, happening in a particularly complex
financing environment, is a great mark of recognition of both the
exceptional results we achieved so far at Micropep and the future
potential of our micropeptide discovery platform and first active
ingredients," said Thomas Laurent, Chief Executive Officer and
co-founder of Micropep. "We are pleased to welcome on board Zebra
Impact Ventures and BPI Green Tech Investment to help us deliver on
our mission to build more sustainable agriculture to protect global
food production for future generations.”
Strategic Partnerships and Future Growth
"Micropeptides have a unique value proposition, combining new
modes of actions, strong efficacy in the field, great safety
profile, and affordable costs for farmers,” Laurent continued. “We
are uniquely positioned to provide a whole new category of
sustainable active ingredients based on micropeptides to the crop
protection industry, working hand-in-hand with selected partners at
different stages of the product development lifecycle. This new
round of financing will help us strengthen our existing
relationships and build new strategic alliances with leading
R&D, manufacturing, commercial, and distribution companies in
our industry. We believe this is the only sustainable way to scale
a company like ours and bring our micropeptide active ingredients
to as many farmers as possible worldwide.”
“In parallel, we will continue our research efforts in France
exploring innovative ways to grow our proprietary discovery
platform and enhance our testing capabilities to maximize impact.
Our investors have shown confidence in our approach, and we will
reward them with an ongoing commitment to creating innovative,
sustainable AgTech solutions for a better world,” he said.
To learn more about Micropep and its Series B funding, visit the
website here.
About Micropep Technologies
Micropep Technologies, with operations in the US and France, is
a global leader in breakthrough micropeptide technology. The
company has developed a proprietary AI-powered discovery platform
for micropeptides, which are short protein molecules naturally
produced by plant cells and have an infinite number of
applications. Micropep is building the next generation of natural
solutions addressing global challenges in multiple markets, with a
key focus in agriculture. For more information about Micropep,
please go to www.micro-pep.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240725006820/en/
Sarah Shkargi sshkargi@cglife.com